Pioneering a cure for cancer

A cure for nasopharyngeal cancer is getting closer to reality. Home-grown firm Tessa Therapeutics is conducting what it says is the world's largest trial of its kind to treat patients through a specialised form of immunotherapy: virus-specific T-cell therapy. Jose Hong explains the science behind it.

A version of this article appeared in the print edition of The Straits Times on September 22, 2017, with the headline 'Pioneering a cure for cancer'. Print Edition | Subscribe